Oaktree Acquisition Corp. III Life Sciences (OACC)
NasdaqGM · USD · Financial Services · Shell Companies
$10.68 (-0.28%) as of
Key statistics
- Market cap
- 262.54M
- P/E (TTM)
- 38.14
- EPS (TTM)
- 0.28
- Dividend yield
- 0.00%
- 52-week range
- 10.50 – 10.93
- Profit margin
- 0.00%
- Volume
- 1.91k
About Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.
- Sector
- Financial Services
- Industry
- Shell Companies
- Headquarters
- Los Angeles, CA, United States
oaktreeacquisitioncorp.com/oac-iii
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.